Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Leap Therapeutics Inc

LPTX
2,98
0,00 (0,00%)
27 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/11/202413:00PRNUSLeap Therapeutics to Participate at Piper Sandler 36th..
13/11/202413:10EDGAR2Form 8-K - Current report
13/11/202413:00PRNUSLeap Therapeutics Reports Third Quarter 2024 Financial..
13/11/202412:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/10/202423:29EDGAR2Form SC 13D/A - General Statement of Acquisition of..
31/10/202422:40EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
04/10/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202413:30EDGAR2Form 8-K - Current report
30/9/202413:00PRNUSLeap Therapeutics Announces Completion of Enrollment in Part..
12/8/202413:10EDGAR2Form 8-K - Current report
12/8/202413:00PRNUSLeap Therapeutics Reports Second Quarter 2024 Financial..
12/8/202412:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/7/202422:48EDGAR2Form 8-K - Current report
23/5/202422:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/5/202413:10EDGAR2Form 8-K - Current report
13/5/202413:00PRNUSLeap Therapeutics Reports First Quarter 2024 Financial..
13/5/202412:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
11/4/202414:30PRNUSLeap Therapeutics Announces $40 Million Private Placement
18/3/202412:00PRNUSLeap Therapeutics Reports Fourth Quarter and Full Year 2023..
01/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/1/202423:28EDGAR2Form 8-K - Current report
16/1/202423:10EDGAR2Form 8-K - Current report
16/1/202423:05PRNUSLeap Therapeutics to Present New Clinical Data from Part A..
03/1/202413:00PRNUSLeap Therapeutics to Participate at the 42nd Annual J.P...
02/1/202413:00PRNUSLeap Therapeutics Announces Completion of Enrollment in..
Apertura: Min: Max:
Chiusura: 2,98

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network